MUC5B and interstitial lung disease: Variation in the promoter of MUC5B was identified as a risk factor for clinically evident sporadic and familial ILD [4] and is associated with the presence of interstitial lung abnormalities (ILAs), a qualitative subclinical ILD phenotype, in the Framingham Heart Study (FHS) [5].